LIVE: Minimal Residual Disease in Solid Tumors: Principles and Applications of Circulating Tumor DNA
LIVE WEBINAR: OCTOBER 29, 2026 | 1:00-2:00pm ET
This course contains the live webinar link (sent via Zoom), recorded webinar, slide handout, pre- and post- knowledge check questions, and continuing education credit (CME and CMLE).
This interactive live webinar is part 25 of the Emerging and Evolving Biomarkers Series.
Description:
Circulating tumor DNA (ctDNA) is emerging as a powerful biomarker for detecting minimal residual disease (MRD) for patients with solid tumors. This webinar will review the principles, technologies, and clinical applications of ctDNA-based MRD detection, with a focus on the opportunities and challenges of identifying molecular evidence of residual disease before it becomes clinically apparent.
Topics will include tumor-informed and tumor-naïve approaches to ctDNA detection, strategies for improving analytical sensitivity and specificity, and the impact of biological and technical factors on assay performance. The webinar will also discuss emerging clinical applications of ctDNA-guided risk stratification, surveillance, and treatment selection across solid tumors, as well as ongoing challenges in translating ctDNA MRD testing into routine clinical practice.Learning Objectives:
- Describe the biological principles underlying ctDNA release and detection and their implications for MRD testing in solid tumors.
- Compare tumor-informed and tumor-naïve approaches to ctDNA-based MRD detection, including key differences in assay design and analytical performance.
- Identify biological and
technical factors that influence the sensitivity, specificity, and
interpretation of ctDNA-based MRD assays.
- Discuss the emerging clinical applications and challenges of ctDNA-based MRD testing, including risk stratification, surveillance, and treatment selection.
Speaker:
Yuxuan Wang, MD, PhD
Johns Hopkins School of Medicine
Moderator:
Pawel Mroz, MD, PhD
University of Minnesota Medical School
Duration: 1 Hour
Live Webinar: October 29, 2026 | 1pm Eastern
How to Register:
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, create a FREE account.
- Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
By registering for this webinar, you are agreeing to abide by the AMP Code of Conduct.
Continuing Education Credit Information
CME credit: 1.0CMLE credit: 1.0
Last day to claim credit: December 31, 2028
Accreditation Statements
AMA PRA Category 1 Credit(s)™
This
activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education through the joint providership of American Society
for Clinical Pathology (ASCP) and Association for Molecular Pathology
(AMP). The American Society for Clinical Pathology (ASCP) is accredited
by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the
ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements
for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.